Gelsomino, L., Gu, G., Rechoum, Y., Beyer, A. R., Pejerrey, S. M., Tsimelzon, A., . . . Fuqua, S. A. (2016). ESR1 Mutations Affect Anti-proliferative Responses to Tamoxifen through Enhanced Cross-Talk with IGF Signaling. Breast Cancer Res Treat.
Stile di citazione ChicagoGelsomino, Luca, et al. "ESR1 Mutations Affect Anti-proliferative Responses to Tamoxifen Through Enhanced Cross-Talk With IGF Signaling." Breast Cancer Res Treat 2016.
Citazione MLAGelsomino, Luca, et al. "ESR1 Mutations Affect Anti-proliferative Responses to Tamoxifen Through Enhanced Cross-Talk With IGF Signaling." Breast Cancer Res Treat 2016.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.